Trials / Withdrawn
WithdrawnNCT01352923
Study of Polymorphisms in pear1 Gene Link to Platelet Activation and Signaling Pathway Variations
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
In this study PEAR1 polymorphisms effects will be analyze in blood platelets to determine how PEAR1 regulates platelet activation.
Detailed description
Several large-scale studies have confirmed the long held notion that platelet responses to different agonists are highly variable, within well defined populations of healthy donors. Single nucleotide polymorphisms in genes encoding platelet proteins can explain the wide range of responses to standard platelet agonists. Yet, numerous SNPs point towards proteins with previously unknown function in platelets, wich modulate the complex network of signaling events that regulate platelet function and further augment variability. PEAR1 is mainly expressed in platelets and endothelial cells. A few studies have linked SNPs in PEAR1 with decreased or increased platelet responses to various agonists. However, hitherto, no direct functional studies have been carried out to determine whether and how PEAR1 modulate intracellular signaling pathways relevant for platelet function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood test | preparation of blood platelets |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2011-05-12
- Last updated
- 2024-06-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01352923. Inclusion in this directory is not an endorsement.